[HTML][HTML] The Niemann-Pick type diseases–A synopsis of inborn errors in sphingolipid and cholesterol metabolism

FW Pfrieger - Progress in lipid research, 2023 - Elsevier
Disturbances of lipid homeostasis in cells provoke human diseases. The elucidation of the
underlying mechanisms and the development of efficient therapies represent formidable …

[HTML][HTML] Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine

M Las Heras, B Szenfeld, RA Ballout, E Buratti… - NPJ Genomic …, 2023 - nature.com
Abstract Niemann-Pick type C (NPC) disease is a lysosomal storage disease (LSD)
characterized by the buildup of endo-lysosomal cholesterol and glycosphingolipids due to …

Trial of N-Acetyl-l-Leucine in Niemann–Pick Disease Type C

T Bremova-Ertl, U Ramaswami, M Brands… - … England Journal of …, 2024 - Mass Medical Soc
Abstract Background Niemann–Pick disease type C is a rare lysosomal storage disorder.
We evaluated the safety and efficacy of N-acetyl-l-leucine (NALL), an agent that potentially …

The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C

JV Pluvinage, J Sun, C Claes, RA Flynn… - Science translational …, 2021 - science.org
Lysosome dysfunction is a shared feature of rare lysosomal storage diseases and common
age-related neurodegenerative diseases. Microglia, the brain-resident macrophages, are …

[HTML][HTML] The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment

C Toro, M Zainab, CJ Tifft - Neuroscience letters, 2021 - ncbi.nlm.nih.gov
The GM2 gangliosidoses, Tay-Sachs (TSD), Sandhoff disease (SD) and GM2 activator
deficiency are rare, progressive, neurodegenerative lysosomal storage disorders (LSDs) …

[HTML][HTML] Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C

T Bremova-Ertl, J Claassen, T Foltan… - Journal of …, 2022 - Springer
Objective To investigate the safety and efficacy of N-acetyl-l-leucine (NALL) on symptoms,
functioning, and quality of life in pediatric (≥ 6 years) and adult Niemann–Pick disease type …

[HTML][HTML] N-Acetyl-l-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice

N Hegdekar, MM Lipinski, C Sarkar - Scientific reports, 2021 - nature.com
Traumatic brain injury (TBI) is a major cause of mortality and long-term disability around the
world. Even mild to moderate TBI can lead to lifelong neurological impairment due to acute …

[HTML][HTML] Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1

K Campbell, NX Cawley, R Luke, KEJ Scott… - Biomarker …, 2023 - Springer
Abstract Background Niemann-Pick disease, type C1 (NPC1) is an ultrarare, recessive,
lethal, lysosomal disease characterized by progressive cerebellar ataxia and cognitive …

[HTML][HTML] N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study

T Fields, T M. Bremova, I Billington, GC Churchill… - Trials, 2023 - Springer
Abstract Background Niemann-Pick disease type C (NPC) is a rare autosomal recessive
neurodegenerative lysosomal disease characterized by multiple symptoms such as …

Current advancements in therapy for Niemann-Pick disease: Progress and pitfalls

T Bremova-Ertl, S Schneider - Expert opinion on pharmacotherapy, 2023 - Taylor & Francis
ABSTRACT Introduction Niemann-Pick disease type C (NPC) is a rare, autosomal recessive,
lysosomal storage disorder. To combat the progressive neurodegeneration in NPC, disease …